Skip to NavigationSkip to content

News

Pfizer Inc is to pay $5.4 billion in cash to acquire sickle cell disease drug-maker Global Blood Therapeutics, according to Proactive Investors.
The Joint Committee on Vaccination and Immunisation (JCVI) has advised that a targeted inactivated polio vaccine (IPV) booster be given to all...
The COVID-19 pandemic caused a huge backlog in patients as medical services focused their efforts on combating the virus. At the start of the year,...
Wastewater surveillance techniques are being adapted for use in monitoring the spread of monkeypox across the San Francisco Bay Area and numerous...
Research, published by Nature Communications, has revealed how the structural brain abnormalities found in a variety of brain disorders is affected...
A February to May 2022 Medscape survey of 1,012 UK doctors revealed that 45% of junior doctors are considering leaving the profession, citing a...
Karuna Therapeutics has announced positive topline results from its Phase III EMERGENT-2 trial, evaluating the efficacy, safety, and tolerability of...
Tagrisso and Hutchmed have revealed positive Phase II data on their combination drug, which prompts the two partners to progress into a Phase III...
A doctor in New York State has warned that there could be hundreds, or even thousands, of undiagnosed cases of polio in the region, according to the...
The FDA has approved MYFEMBREE as a one-pill, once-a-day therapy for the management of moderate to severe pain associated with endometriosis in pre-...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches